Sophia Genetics (SOPH) and A.D.A.M. Innovations said Thursday they are partnering to bring liquid biopsy genomic testing to Japan.
The companies said they will also partner to commercialize a liquid biopsy companion diagnostic for personalized and precision cancer care in the country.
Shares of Sophia were up over 4% in recent trading.
Price: 4.47, Change: +0.18, Percent Change: +4.17